Escuche esta historia
--:--
2:24
Sebastian Piñera announces fourth dose application in Chile
The president of Chile, Sebastián Piñera, reported this Thursday, January 6, that next Monday the mission of vaccinating the population with the fourth dose of the antibody against COVID-19 will begin, with the most vulnerable population being the one that would have priority to receive said vaccine.
This is a critical moment in the country due to the increase in cases of infected in recent days. Although the numbers are not as high as the peaks at the beginning of the pandemic, Piñera considers it prudent to place a fourth dose.
The President, from the royal residence of La Moneda, assured in a public interview that, as of next Monday, January 10, another mass immunization process will begin with a fourth dose or the so-called second portion of sponsorship.
Science has shown that the effectiveness of vaccines decreases with the passage of time and also with the appearance of new variants. This led Piñera to make the decision.
The vaccination process with the fourth dose would start with immunocompromised people, who should boost their immune system as soon as possible.
People over 55 years of age could start getting the vaccine as of February 7, as long as they have completed 6 months of their previous dose.
Chile has vaccines from Pfizer (United States), Cansino (China), Sinovac (China) and AstraZeneca (United Kingdom). Shipments of the vaccine from Moderna, United States, are expected to arrive in early February.
More than 14 million Chileans completed their immunization cycle, and 11.2 million obtained a third dose of support.
On March 11 of this year, it would be two years since the World Health Organization (WHO) classified the COVID-19 disease caused by the new SARS-CoV-2, identified for the first time at the end of 2019, as a pandemic.
With a total of 1,817,300 infected people in Chile, only 39,207 have died. Worldwide there are 293,750,692 confirmed cases and 5,454,131 deaths, according to the latest WHO report.
